Purchase Order 75N94025P00481

Award Date 8/11/25
Potential Completion Date 8/10/26
Potential Value $18K
Ultimate Awardee
Not listed
PSC Category
6810 - Chemicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sacramento, CA 95817, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Novogene Corp Inc., a minority-owned small business. The contract, valued at $13,748.40, is for RNA sample quality control services. No set-aside was used. Novogene is a provider of next-generation sequencing and bioinformatics services, and has established a significant relationship with federal agencies through numerous prime contract and...
This $20,850 firm fixed-price purchase order was awarded to Novogene Corp Inc., a minority-owned small business, by the National Institute of Allergy and Infectious Diseases (NIAID) on September 12, 2024. The contract is for RNA sequencing services to support NIAID's biomedical research efforts, with a completion date of September 11, 2025. Novogene is an experienced provider of genomic sequencing and bioinformatics services to various federal agencies, holding multiple prime contracts and...
This federal contract award is for $14,072.00 and was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Novogene Corporation Inc., a minority-owned small business based in Sacramento, California. The contract is for pre-made libraries lane sequencing services, which involves advanced next-generation sequencing technologies including whole genome, transcriptome, metagenomic, and RNA sequencing. This contract has an ultimate completion date of June 30, 2025 and is a...
This is a $25,000 Firm Fixed Price purchase order awarded by the National Institute of Mental Health (NIMH) to Novogene Corporation Inc., a minority-owned small business in Sacramento, California. The contract is not set aside. Novogene is providing advanced genomic sequencing and bioinformatics services to support NIMH's scientific research programs. This includes services such as whole genome, transcriptome, metagenomic, and RNA sequencing. Novogene has previously secured multiple federal...
This is a $24,900 firm fixed-price purchase order awarded by the Shared Services Center of a civilian federal agency to Novogene Corporation Inc., a minority-owned small business headquartered in Sacramento, California. The contract is for the performance of metagenomics sequencing on 110 samples, with a 2x150bp sequencing depth and a target of 30 million reads per sample. The award does not utilize a set-aside designation. Novogene Corporation specializes in providing advanced genomic...
This is a $13,400 firm fixed-price purchase order contract awarded by the National Eye Institute, a civilian agency within the National Institutes of Health, to Novogene Corp Inc., a minority-owned small business. The contract is for cell handling and sequencing services, with a period of performance through September 30, 2024. Novogene is a genomics services provider that specializes in next-generation DNA and RNA sequencing, bioinformatics, and research support for federal agencies across...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to Novogene Corp Inc., a minority-owned small business, for RNA sequencing analysis services. The $10,880 contract has a completion date of December 11, 2024 and was not set aside. Novogene is a provider of genomic sequencing and bioinformatics services, supporting various federal agencies' biomedical, agricultural, environmental, and basic research efforts. This award...
Novogene Corp Inc., a minority-owned small business, has been awarded a firm fixed price purchase order contract valued at $24,350 by the Department of Health and Human Services' National Institutes of Health National Cancer Institute. The contract is for laboratory testing services to support genomic sequencing and bioinformatics research efforts. Specifically, Novogene will provide DNA/RNA sample sequencing and data analysis services leveraging Illumina and PacBio platforms, including whole...
This is a firm fixed-price purchase order awarded by the Plains Area division of a civilian federal agency to Novogene Corporation Inc., a minority-owned small business. The contract, valued at $62,346.90, is for genomic sequencing services and covers the period through December 31, 2024. Novogene is a provider of next-generation sequencing technologies, including whole genome, exome, transcriptome, and metagenomic sequencing, and has delivered these services to various government agencies...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Novogene Corp Inc., a minority-owned small business specializing in genomic sequencing and bioinformatics services. The $12,866.00 contract is for mRNA sequencing services to support NIAID's biomedical research efforts. Novogene has established itself as a key provider of DNA and RNA sequencing, library preparation, and data analysis services to various federal agencies,...

This is a firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Novogene Corporation Inc., a minority-owned small business located in Sacramento, California. The contract is for lane sequencing and related services, with a ceiling value of $17,640.00 and a period of performance through August 10, 2026. This contract is not a set-aside.

Novogene Corporation Inc. is an experienced provider of advanced genomic sequencing and bioinformatics services, having secured numerous federal contracts with agencies such as the National Institutes of Health, NOAA, USDA, VA, and USGS. The company specializes in whole genome, transcriptome, metagenomic, and RNA sequencing, supporting research across biomedical, agricultural, environmental, and basic science domains. This specific contract award indicates Novogene's continued role in delivering specialized genomic analysis capabilities to support the research programs of the NIDDK.

Generated 8/9/25, 9:42 AM